Intrinsiqs

Is AN2 Therapeutics, Inc. overvalued?

AN2 Therapeutics, Inc. (ANTX) — key valuation metrics and fundamentals.

No verdict
Price
$5.99
Fair value
Current P/E
Normal P/E
Market cap
$215.7M
Dividend yield
44.7%
Return on equity
-52.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ANTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.